Orchid Pharma Limited has submitted a regulatory disclosure pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The disclosure intimates that Mr. Mridul Dhanuka, Whole Time Director of the company, will be participating in an Investor Roadshow scheduled as follows:
- Date: Wednesday, July 29, 2026 to Friday, July 31, 2026
- Meeting Type: Group Meet
- Mode: Physical
- Location: Singapore
The company notes that the schedule may undergo changes due to unforeseen exigencies on the part of investors or the company, and any changes will be communicated accordingly.
Importantly, the company explicitly states that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during these investor meetings.